Teijin Pharma Obtains Approval for Bonalon Jelly

August 16, 2012
Bonalon Jelly 35 mg Teijin Pharma said on August 15 that the Ministry of Health, Labor and Welfare (MHLW) approved Bonalon Jelly 35 mg (alendronate sodium hydrate) on the same day. It is the world’s first osteoporosis drug in an...read more